Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Reports & Briefings
Attacks by US government and industry on India’s patent law and generic competition began to intensify after India issued a compulsory license in 2012 and further amplified after the Indian Supreme Court’s landmark 2013 decision to uphold the rejection of a patent for a life saving leukemia drug.
Last updated 22 January 2015
Last updated 14 January 2015
2nd Edition January 2015 Immunisation is one of the most efficient ways to reduce child mortality. Yet, every year 1 out of every 5 children (under the age of 1 year) is not fully vaccinated, putting them at risk of dying of preventable diseases such as measles, pneumonia or diarrhoea.
Last updated 9 December 2014
The European Union’s (EU) free trade and research and development (R&D) policies promote excessive intellectual property (IP) protection. This approach jeopardises access to affordable, needed medicines and impedes needs-driven biomedical innovation.
Last updated 24 November 2014
Issue Brief: Achieving undetectable: what questions remain in scaling-up HIV virologic treatment monitoring?
Last updated 19 November 2014
Intro: As of 7 November 2014, there have been nearly 14,000 reported cases of Ebola virus disease in West Africa and nearly 5,000 deaths. The number of new cases is thought to currently double every three weeks. The Ebola outbreak is already a major humanitarian crisis; it is likely to turn into a disaster on a much larger scale if our collective response is not radically improved.
Last updated 12 November 2014
A survey of TB diagnostic and treatment practices in eight countries
Last updated 20 October 2014
2014 Briefing Note The Trans-Pacific Partnership (TPP) trade deal is currently being negotiated between the US and eleven other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam.
Last updated 13 August 2014
MSF issue brief “Pushing the envelope – does the Global Fund’s New Funding Model foster country ambitions”
Since the Global Fund to Fight AIDS, TB and Malaria (GF) cancelled its funding round in 2011, Médecins Sans Frontières (MSF), governments, and people affected by the three diseases have all called for international efforts to scale up HIV, TB and malaria programmes to be put back on track.
Last updated 12 August 2014
This 17th edition of Untangling the Web of Antiretroviral Price Reductions is a departure from recent previous years. For this edition, the methods of collecting information on the sources and prices of antiretrovirals (ARVs) remain the same, but information is presented in a new, shorter format focusing on a few key drugs as well as future regimens, along with an analysis of the current opportunities, challenges and threats faced in keeping the price of ARVs down. DOWNLOAD THE BRIEFING DOCUMENT